<p>Real-World Safety and Effectiveness of Tadalafil in Patients with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Japanese Post-Marketing Surveillance Study</p>-Reference-Cited by-同舟云学术

Real-World Safety and Effectiveness of Tadalafil in Patients with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Japanese Post-Marketing Surveillance Study

Published:2020-05 Issue: Volume:Volume 11 Page:45-54
ISSN:1179-7266
Container-title:Pragmatic and Observational Research
language:en
Short-container-title:POR

Author:

Yamazaki Hiroyoshi,Tsujimoto Naoto,Koyanagi Momoha,Katoh Megumi C^ORCID,Tajima Koyuki,Komori Mika

Publisher

Informa UK Limited

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference19 articles.

1. Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasia

2. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction

3. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol. 2003;170(2):530–547. doi:10.1097/01.ju.0000078083.38675.79

4. Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study

5. Japanese Ministry of Health, Labour and Welfare. The results of the 2017 patient survey. Japanese government official statistics of Japan website. [Updated March 29, 2019]. Available from: https://www.e-stat.go.jp/dbview?sid=0003318621. Accessed July 17, 2019.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discontinuation Rates of Tadalafil Alone and in Combination with a-Blockers in the Treatment of Male Lower Urinary Tract Symptoms with or without Coexisting Erectile Dysfunction: A Systematic Review and Meta-Analysis;International Journal of Clinical Practice;2022-11-03

2. Tadalafil 5 mg Once Daily Improved Each IPSS Subscore, QOL, and Nocturia in Elderly BPH Patients over 70 Years Old in a Real-World Clinical Setting;Urologia Internationalis;2021-10-21